Course curriculum

  • 1

    Integrating Sexual Health and Oncology: 2 CPD Points

    • 01 - Sexual Health among Adolescent and young Adult Cancer Survivors - Vicky Lehmann

    • 02 - The IARC Handbooks of Cancer Prevention Body Fatness and Cancer - Kurt Straif

    • 03 - Cultural Perspectives of Life and Death in the Context of Cancer - Richard Greil

  • 2

    CPD Points

    • Lesson 1: Getting your CPD Points

    • Lesson 2: HPCSA Evaluation Form

    • Lesson 3: Contact Details and Links

What you'll learn

This cutting-edge course equips healthcare providers with the essential knowledge and skills to elevate their care for cancer survivors.

Learn from the experts

Dive deep into topics like sexual health among young cancer survivors, groundbreaking cancer prevention strategies, and cultural perspectives on life and death in the cancer context. Gain the power to confidently navigate sensitive conversations, provide evidence-based prevention techniques, and deliver culturally attuned care. Elevate your practice, make a lasting impact, and transform the lives of cancer survivors with this game-changing course!

  • Vicky Lehmann

    Vicky Lehmann, a dedicated researcher, primarily focuses on childhood cancer survival and involvement in psychosomatic and psychometric research. With a specialisation in medical psychology, Vicky's research centres on the experiences of young adult survivors of childhood cancer, particularly their self-perceptions, interpersonal relationships, and psychosexual development.

    Vicky's affiliation with the ARD (Amsterdam Reproduction and Development) and CCA (Cancer Center Amsterdam) highlights her commitment to conducting research in collaboration with esteemed institutions.

    As a Research Associate, Vicky's primary responsibilities revolve around advancing the field of psycho-oncology, with a particular emphasis on cancer survivorship, (onco)fertility, young adults, psychosexual development, and sexuality.

    With a postdoctoral research fellowship, Vicky brings expertise and a passion for exploring the psychological and psychosocial aspects of cancer survivorship. In addition, her educational background in psychology further supports their research endeavours.

  • Dr Kurt Straif

    Kurt Straif, with his background in clinical oncology, occupational and environmental medicine, and epidemiology, conducts research to identify various risk and preventive factors of cancer.

    His work is dedicated to supporting global cancer control efforts aligned with the SDG 2030 agenda, specifically SDG 3, Health, primarily focusing on non-communicable diseases. Previously, Kurt Straif served as the Head of the IARC Monographs Program and the Section of Evidence Synthesis and Classification at the International Agency for Research on Cancer (IARC/WHO) in Lyon, France.

    During his tenure, he led significant projects such as assessing the carcinogenicity of tobacco, air pollution, radiofrequency electromagnetic fields, shift-work and circadian disruption. He also contributed to developing the IARC Handbooks of Cancer Prevention, covering obesity avoidance and breast and colorectal cancer screening. Kurt Straif's expertise extends to his involvement in the Global Burden of Disease project, which informs global and local policies for cancer prevention.

    Currently, he serves as a Research Professor at Boston College, continuing his important work in cancer prevention and control.

  • Prof Richard Greil

    Richard Greil is a renowned expert in the field of oncology and haematology. He currently holds multiple positions at the University Clinic of Internal Medicine III, Paracelsus Medical University Salzburg/Uniklinikum. As the Head of the Department and the Laboratory of Immunological and Molecular Cancer Research (LIMCR), he spearheads groundbreaking research in the pathophysiology of various cancers, including chronic lymphocytic leukaemia, Non-Hodgkin lymphoma, AML, breast cancer, and head and neck cancer.

    Additionally, Richard serves as the Head of the Center for Clinical Cancer and Immunology Trials (CCCIT) at the Salzburg Cancer Research Institute (SCRI), leading innovative clinical trials in the field.

    Richard Greil also holds leadership positions as the Head of the Cancer Cluster Salzburg (CCS) and Chairman of the Austrian Group of Medical Tumor Therapy (AGMT). With his extensive expertise and scientific interests, Richard plays a vital role in advancing cancer research and improving patient outcomes.